Martin Shkreli attributes arrest to drug-price hikes
The University of California at Davis and Moffitt Cancer Center in Florida have suspended a planned drug trial sponsored by KaloBios Pharmaceuticals Inc. following the arrest of Chief Executive Officer Martin Shkreli on securities fraud charges.
Posted On Dec 20 2015